August 19, 2020 by Chain Drug Review
American Pharmacists Association, B. Douglas Hoey, National Alliance of State Pharmacy Associations, National Community Pharmacists Association, Rebecca Snead, Scott Knoer
Pharmacy
ALEXANDRIA, Va. – The fastest and surest way to immunize millions of Americans against COVID-19 is to enlist local pharmacists who see more patients per year than primary physicians, a group of national pharmacy organizations told the National Governors Association today. “To realize the positive outcomes hoped for, all community-based pharmacists and pharmacies must be part of
August 7, 2020 by Chain Drug Review
B. Douglas Hoey, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — National Community Pharmacists Association CEO B. Douglas Hoey issued the following statement on President Trump’s new executive order calling for the federal government to buy “essential” drugs and supplies made in the U.S. rather than those from overseas companies: “We wouldn’t buy all our essential equipment for a military operation from China
July 28, 2020 by Chain Drug Review
B. Douglas Hoey, NCPA, Paycheck Protection Program
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association supports provisions in Senate Republican coronavirus relief legislation presented Monday that would shield essential small businesses from opportunistic lawsuits, provide additional funding for the Paycheck Protection Program and offer tax credits to offset costs of safety precautions, said NCPA CEO B. Douglas Hoey. Policymakers should swiftly negotiate
July 27, 2020 by B. Douglas Hoey
B. Douglas Hoey, NCPA, pharmacy
July 27, 2020, Opinion
The more than 20,000 community pharmacies in the United States serve as a patient safety net for their communities during normal times and during times of emergencies. Hurricanes Sandy, Michael and Katrina. Tornadoes. Floods in the South and Midwest. Wildfires in California. The coronavirus we’re currently facing has been a bit different from some of
July 22, 2020 by Chain Drug Review
B. Douglas Hoey, DIR fees, Trump administration
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — In a letter to President Trump, National Community Pharmacists Association CEO B. Douglas Hoey says that as part of any efforts on drug pricing, the administration must eliminate back-door fees that insurance companies use to increase drug costs for seniors and gouge local pharmacies. “Insurance companies are using their prescription drug management divisions
July 15, 2020 by Chain Drug Review
B. Douglas Hoey, COVID-19, National Community Pharmacists Association
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The next COVID-19 package should shield essential small businesses from opportunistic lawsuits, extend the Paycheck Protection Program, provide or ensure hazard pay, and let pharmacists administer tests and vaccines, according to the National Community Pharmacists Association, which launched its “Essential” campaign today via social media. “Essential businesses are taking great precautions, sometimes
June 3, 2020 by Chain Drug Review
B. Douglas Hoey, The National Community Pharmacists Association
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association issued the following statement Wednesday on behalf of CEO B. Douglas Hoey in response to reports on the destruction of small business local pharmacies: “In recent days we have received reports from long-time members that their pharmacies were damaged and looted in the rioting that broke out
April 28, 2020 by Chain Drug Review
B. Douglas Hoey, COVID-19 testing, independent pharmacies, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The administration’s effort to enlist pharmacies as COVID-19 testing centers must include independent, locally-owned pharmacies, otherwise millions of Americans will be left out, said the National Community Pharmacists Association. “One out of five zip codes in the United States don’t have a big chain drug store. They’re served by locally-owned, small business independent
April 26, 2020 by Chain Drug Review
B. Douglas Hoey, COVID-19, Gov. Andrew Cuomo, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association, which represents over 21,000 independent pharmacies across the country, issued the following statement on behalf of CEO B. Douglas Hoey in response to New York Governor Andrew Cuomo’s executive order authorizing New York’s small business independent pharmacies to serve as COVID-19 testing collection centers: “We are deeply
April 7, 2020 by Chain Drug Review
B. Douglas Hoey, COVID-19, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — A new nationwide analysis of pharmacies shows there are millions of Americans whose only option is a local independent, something policymakers and suppliers must keep in mind as they make their battle plans for COVID-19, said the National Community Pharmacists Association on Tuesday. “There are thousands of communities in which the only
March 17, 2020 by Chain Drug Review
2019 Novel Coronavirus (COVID-19), B. Douglas Hoey, Mike Pence and members of the administration’s Coronavirus Task Force, The National Community Pharmacists Association
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association today reiterated to vice president Mike Pence and members of the administration’s Coronavirus Task Force how community pharmacy is ready and willing to assist with fighting the pandemic, as well as allowances needed in order for small business neighborhood pharmacies to continue to provide life-saving assistance to
February 18, 2020 by Chain Drug Review
B. Douglas Hoey, FTC and DOJ issued draft guidelines on vertical mergers in the health care industry., National Community Pharmacists Association
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The surge in vertical integration in the health care industry has created “an oligopoly of integrated health care companies controlling nearly all aspects of the health care and pharmacy supply chain,” said the National Community Pharmacists Association in comments submitted Tuesday to the Federal Trade Commission and the U.S. Department of Justice
February 12, 2020 by Chain Drug Review
B. Douglas Hoey, National Community Pharmacists Association, National Community Pharmacists Association during NCPA’s recent annual convention in Boston, XIL Consulting
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – A new report by one of the country’s top pharmacy industry analysts shows how giant corporate middlemen are using “obscure” fees to scoop up billions in additional profits at the expense of patients and their neighborhood pharmacies, said the National Community Pharmacists Association on Wednesday. “It should be shocking to state and
January 14, 2020 by B. Douglas Hoey
B. Douglas Hoey, NCPA, pharmacy
January 6, 2020, Opinion
One thing that can be said about the state of prescription medications in 2019 is that the pharmacy payment model is complex, convoluted and confusing. That’s how I began this column last year. And although some progress has been made in moving the model toward a system that better serves patients, that sentence still does